Baystreet.ca News Commentary – Pharmaceutical markets are witnessing drug delivery devices surge toward $862.16 billion by ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the continuous glucose monitoring (CGM) market. A strong third-quarter 2025 performance and a series ...

Richie Murphy’s squad come into this weekend having narrowly lost at both Cardiff in the Challenge Cup and against Leinster ...

Our study assessed the impact of using Control-IQ technology, an automated insulin delivery system, on achievement of a Healthcare Effectiveness Data and Information Set (HEDIS) quality measure ...

Richie Murphy’s side took 34 minutes to score their first points of the night, before Connacht set up a nervy finish.

Johnson & Johnson Medtech announced the expansion of its Research, Development, and Innovation (RD&I) activities at its ...

Neither had a great year in 2025, but the future is looking bright.

DexCom, which has underperformed its medical equipment and S&P 500 peers in a big way in 2025, could be staring at better prospects next year. Stelo is facing vast and underpenetrated prediabetes and ...

BlackRock Mid Cap Growth Equity Fund reported 0.72% returns for 3Q2025. Review our latest analysis to learn how selective ...

As someone who played it during its early access period, I was immediately surprised by how much Grounded has evolved for its 1.0 launch. It feels like it’s not only fulfilled the potential of its ...

“Grand Rapids,” by Natasha Stagg, is an unassuming portrait of a Midwestern teenager’s grief and transformation. By Meghan O’Gieblyn Need something to read (or watch) this New Year’s week? This quiz ...

If you are wondering whether Medtronic at around $98 is still a smart buy or if most of the upside is already priced in, this article will walk through what the market might be missing. The stock is ...